Glass House Brands (GLAS) Non Operating Investment Income (2021 - 2022)
Glass House Brands' (GLAS) quarterly Non Operating Investment Income came in at -$3.3 million in Q4 2022, up 53.85% year-on-year from -$2.1 million in Q4 2021, and down 100.0% on a QoQ basis from $871.3 billion in Q3 2022.
Glass House Brands (GLAS) Non Operating Investment Income (2021 - 2022) Analysis & Trends
Glass House Brands (GLAS) has 2 years of Non Operating Investment Income data on file, last reported at -$3.3 million in Q4 2022.
- On a quarterly basis, Non Operating Investment Income rose 53.85% year-over-year to -$3.3 million in Q4 2022; TTM through Dec 2022 was $1439.8 billion, a 153.27% increase from a year earlier, with the FY2022 full-year figure at -$2.0 million, down 132.95% from the prior year.
- Non Operating Investment Income for Q4 2022 stood at -$3.3 million, down from $871.3 billion in the prior quarter.
- Over the last five years, Non Operating Investment Income for GLAS reached as high as $871.3 billion in Q3 2022 and fell as low as -$7.2 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.30 Mn |
| Dec 31, 2022 | -3.30 Mn |
| Sep 30, 2022 | 871.33 Bn |
| Sep 30, 2022 | 871.33 Bn |
| Dec 31, 2021 | -7.16 Mn |
| Dec 31, 2021 | -7.16 Mn |
| Sep 30, 2021 | 568.47 Bn |
| Sep 30, 2021 | 568.47 Bn |
| Jun 30, 2021 | -19,437.00 |
| Jun 30, 2021 | -19,437.00 |
| Mar 31, 2021 | 6.09 Mn |
| Mar 31, 2021 | 6.09 Mn |